{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:42:50Z","timestamp":1791913370627,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1053\/j.akdh.2024.10.004","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T13:09:55Z","timestamp":1743599395000},"page":"2-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Podocytopathies"],"prefix":"10.1053","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7381-7516","authenticated-orcid":false,"given":"Mariela","family":"Navarro-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wooden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick","family":"Santoriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Bomback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.akdh.2024.10.004_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of Autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.10.004_bib1","first-page":"217","article-title":"The glomerular tip lesion: a steroid responsive nephrotic syndrome","volume":"27","author":"Beaman","year":"1987","journal-title":"Clin Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2024.10.004_bib2","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.ASN.0000135051.62500.97","article-title":"Focal segmental glomerulosclerosis in nephrotic adults","volume":"15","author":"Chun","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.10.004_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/snep.2003.50012","article-title":"Pathologic classification of focal segmental glomerulosclerosis","volume":"23","author":"D\u2019Agati","year":"2003","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.10.004_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2215\/CJN.07110615","article-title":"Treatment with glucocorticoids or calcineurin inhibitors in primary FSGS","volume":"11","author":"Laurin","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.10.004_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0272-6386(13)80001-7","article-title":"Reversible renal failure in the nephrotic syndrome","volume":"19","author":"Smith","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.akdh.2024.10.004_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5414\/CN111218","article-title":"Implication of acute tubular injury in minimal change nephrotic syndrome","volume":"101","author":"Grainer","year":"2024","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.10.004_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/kisup.2011.14","article-title":"Pharmacogenetics of tacrolimus: Ready for clinical translation?","volume":"1","author":"Coto","year":"2011","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1053\/j.akdh.2024.10.004_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1053\/j.ajkd.2019.12.019","article-title":"Approach to diagnosis and management of primary glomerular diseases due to podocytopathies in adults: Core curriculum 2020","volume":"75","author":"Ahn","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.10.004_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.akdh.2024.03.009","article-title":"Focal segmental glomerulosclerosis","volume":"31","author":"Suresh","year":"2024","journal-title":"Adv Kidney Dis Health"},{"issue":"3","key":"10.1053\/j.akdh.2024.10.004_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.ackd.2013.01.012","article-title":"Renal physiology of pregnancy","volume":"20","author":"Cheung","year":"2013","journal-title":"Adv Chron Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.10.004_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.akdh.2024.04.001","article-title":"Genetic causes of nephrotic syndrome and focal and segmental glomerulosclerosis","volume":"31","author":"Caparali","year":"2024","journal-title":"Adv Kidney Dis Health"},{"issue":"9","key":"10.1053\/j.akdh.2024.10.004_bib11","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.mayocp.2021.01.037","article-title":"Identification of genetic causes of focal segmental glomerulosclerosis increases with proper patient selection","volume":"96","author":"Miao","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1053\/j.akdh.2024.10.004_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2898","article-title":"Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome","volume":"46","author":"Tory","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.akdh.2024.10.004_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfv325","article-title":"Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis","volume":"31","author":"Gast","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2024.10.004_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2024.10.004_bib17","first-page":"1326","article-title":"Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial","volume":"8","author":"Ponticelli","year":"1993","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.akdh.2024.10.004_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/ckj\/sfaa191","article-title":"Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis","volume":"14","author":"Xue","year":"2020","journal-title":"Clin Kidney J"},{"issue":"Suppl 1","key":"10.1053\/j.akdh.2024.10.004_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000481634","article-title":"Protecting podocytes: a key Target for therapy of focal segmental glomerulosclerosis","volume":"47","author":"Campbell","year":"2018","journal-title":"Am J Nephrol"},{"issue":"4S","key":"10.1053\/j.akdh.2024.10.004_bib20","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.10.004_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2024.10.004_bib22","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","article-title":"A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group","volume":"56","author":"Cattran","year":"1999","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2024.10.004_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.akdh.2024.10.004_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fped.2015.00078","article-title":"The evidence-based approach to adult-onset idiopathic nephrotic syndrome","volume":"3","author":"Canetta","year":"2015","journal-title":"Front pediatr"},{"issue":"10","key":"10.1053\/j.akdh.2024.10.004_bib25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.autrev.2018.04.007","article-title":"Does cyclophosphamide still play a role in glomerular diseases?","volume":"17","author":"Ponticelli","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1053\/j.akdh.2024.10.004_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Prim"},{"issue":"12","key":"10.1053\/j.akdh.2024.10.004_bib27","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2215\/CJN.06890618","article-title":"Adrenocorticotropic hormone for childhood nephrotic syndrome: the ATLANTIS randomized trial","volume":"13","author":"Wang","year":"2018","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924001563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924001563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T01:20:43Z","timestamp":1745025643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813924001563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2949813924001563"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.10.004","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Podocytopathies","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}